13F-HR filed by Opti Capital Management, LP
Opti Capital Management, LP filed this 13F-HR for the quarter ended 2021-03-31, filed 2021-05-17, with 35 holding rows worth $819,254,000.
- Accession
- 0000919574-21-003632
- Filer
- CIK 1738654
- Filed
- 2021-05-17
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2021
A holdings report, 35 entries on the cover page, a total value of $819,254,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $819,254,000 with VALUE read as thousands by filing date, 13F file number 028-19379. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NUANCE COMMUNICATIONS INC | 67020YAK6 | DBCV 1.000%12/1 | 54,544,000 | $101,015,000 | thousands by filing date | principal |
| TERADYNE INC | 880770AG7 | NOTE | 23,202,000 | $89,300,000 | thousands by filing date | principal |
| NEW RELIC INC | 64829BAB6 | NOTE 0.500% 5/0 | 63,328,000 | $62,200,000 | thousands by filing date | principal |
| AVAYA HLDGS CORP | 05351XAB7 | NOTE 2.250% 6/1 | 36,500,000 | $45,360,000 | thousands by filing date | principal |
| AKAMAI TECHNOLOGIES INC | 00971TAJ0 | NOTE 0.125% 5/0 | 36,240,000 | $43,996,000 | thousands by filing date | principal |
| REALPAGE INC | 75606NAB5 | NOTE | 20,000,000 | $41,728,000 | thousands by filing date | principal |
| SNAP INC | 83304AAB2 | NOTE 0.75% 08/01/2026 | 17,500,000 | $41,329,000 | thousands by filing date | principal |
| II VI INC | 902104AB4 | NOTE 0.250% 9/0 | 24,900,000 | $38,013,000 | thousands by filing date | principal |
| SUPERNUS PHARMACEUTICALS | 868459AD0 | BOND | 37,347,000 | $36,345,000 | thousands by filing date | principal |
| MANDIANT INC | 31816QAD3 | NOTE 1.625% 6/0 | 34,833,000 | $34,701,000 | thousands by filing date | principal |
| EXACT SCIENCES CORP | 30063PAA3 | NOTE 1.000% 1/1 | 17,483,000 | $32,858,000 | thousands by filing date | principal |
| TRAVERE THERAPEUTICS INC | 761299AB2 | NOTE 2.500% 9/1 | 27,582,000 | $28,016,000 | thousands by filing date | principal |
| LIBERTY MEDIA CORP DELAWARE | 531229AE2 | DEB 2.250% 9/3 | 21,808,156 | $22,634,000 | thousands by filing date | principal |
| LUMENTUM HLDGS INC | 55024UAB5 | NOTE 0.250% 3/1 | 13,000,000 | $20,910,000 | thousands by filing date | principal |
| RAMBUS INC DEL | 750917AG1 | NOTE 1.375% 2/0 | 13,500,000 | $16,184,000 | thousands by filing date | principal |
| Omeros Corp | 682143AE2 | NOTE 6.250%11/1 | 13,200,000 | $15,874,000 | thousands by filing date | principal |
| VONAGE HLDGS CORP | 92886TAJ1 | NOTE 1.750% 6/0 | 15,070,000 | $15,811,000 | thousands by filing date | principal |
| CYTOKINETICS INC | 23282WAA8 | NOTE 4.000%11/1 | 6,500,000 | $15,486,000 | thousands by filing date | principal |
| IONIS PHARMACEUTICALS INC | 462222AB6 | NOTE 0.125%12/1 | 14,500,000 | $13,865,000 | thousands by filing date | principal |
| PLURALSIGHT INC | 72941BAB2 | NOTE 0.375% 3/0 | 13,500,000 | $13,310,000 | thousands by filing date | principal |
| INFINERA CORP | 45667GAE3 | BOND | 7,600,000 | $11,119,000 | thousands by filing date | principal |
| FLEXION THERAPEUTICS INC | 33938JAB2 | NOTE | 12,158,000 | $10,988,000 | thousands by filing date | principal |
| PTC THERAPEUTICS INC | 69366JAB7 | NOTE | 8,500,000 | $9,796,000 | thousands by filing date | principal |
| KARYOPHARM THERAPEUTICS INC | 48576UAA4 | BOND | 9,000,000 | $9,367,000 | thousands by filing date | principal |
| OPKO HEALTH INC | 68375NAD5 | NOTE 4.500% 2/1 | 6,200,000 | $8,296,000 | thousands by filing date | principal |
| ALTERYX INC | 02156BAD5 | BOND | 8,500,000 | $8,027,000 | thousands by filing date | principal |
| APELLIS PHARMACEUTICALS INC | 03753UAB2 | NOTE 3.500% 9/1 | 5,000,000 | $7,043,000 | thousands by filing date | principal |
| 8X8 INC NEW | 282914AB6 | BOND | 5,000,000 | $6,966,000 | thousands by filing date | principal |
| IRONWOOD PHARMACEUTICALS INC | 46333XAF5 | BOND | 5,300,000 | $5,870,000 | thousands by filing date | principal |
| EVOLENT HEALTH INC | 30050BAD3 | NOTE 1.500%10/1 | 5,000,000 | $4,765,000 | thousands by filing date | principal |
| NUTANIX INC | 67059NAB4 | NOTE 1/1 | 3,761,000 | $3,684,000 | thousands by filing date | principal |
| OMEROS CORP | 682143AG7 | NOTE 5.250% 2/1 | 2,000,000 | $2,498,000 | thousands by filing date | principal |
| INFINERA CORP | 45667G103 | COMMON STOCK | 104,517 | $1,006,000 | thousands by filing date | |
| AT&T Inc | 00206R102 | COM | 17,800 | $539,000 | thousands by filing date | |
| ITRON INC COM | 465741106 | Stock | 4,000 | $355,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-21-003632 | this filing | 2021-05-17 | acceptance time not in the bulk data set |